Quanterix Corporation Accumulated Other Comprehensive Income
Quanterix Corporation (QTRX) had Accumulated Other Comprehensive Income of -$1.17 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-10
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.17M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.01M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$723.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$818.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | -$1.17M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | -$1.01M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | -$723.00K 10-Q · filed 2026-08-10 | |
| 2025-09-30 | -$818.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | -$928.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | -$1.82M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | -$3.08M 10-K · filed 2026-03-02 | |
| 2024-09-30 | -$1.41M 10-Q · filed 2024-12-26 | |
| 2024-06-30 | -$3.07M 10-Q/A · filed 2024-12-26 | -$3.15M 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$2.95M 10-Q/A · filed 2024-12-26 | -$3.04M 10-Q · filed 2024-05-08 |
| 2023-12-31 | -$1.67M 10-K · filed 2025-03-17 | -$1.76M 10-K · filed 2024-02-29 |
| 2023-09-30 | -$3.13M 10-K/A · filed 2024-12-26 | -$3.21M 10-Q · filed 2023-11-08 |
| 2023-06-30 | -$2.74M 10-K/A · filed 2024-12-26 | -$2.83M 10-Q · filed 2023-08-08 |
| 2023-03-31 | -$2.50M 10-K/A · filed 2024-12-26 | -$2.58M 10-Q · filed 2023-05-09 |
| 2022-12-31 | -$2.54M 10-K/A · filed 2024-12-26 | -$2.62M 10-K · filed 2023-03-06 |
| 2022-09-30 | -$3.00M 10-K/A · filed 2024-12-26 | |
| 2022-06-30 | -$2.20M 10-K/A · filed 2024-12-26 | |
| 2022-03-31 | -$756.00K 10-K/A · filed 2024-12-26 | |
| 2021-12-31 | $441.00K 10-K · filed 2023-03-06 | |
| 2021-09-30 | $1.05M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $1.58M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $1.18M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $2.43M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $734.00K 10-Q · filed 2020-11-06 | |
| 2020-06-30 | -$26.00K 10-Q · filed 2020-08-04 | |
| 2020-03-31 | -$1.20M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | -$153.00K 10-K · filed 2022-03-01 | |
| 2019-09-30 | -$1.14M 10-Q · filed 2019-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |